News related to Rituxan (Rituximab) and/or conditions it is approved for
Data show new Roche leukemia drug may improve on Rituxan
Source: Yahoo! Health News [2013.05.16]
By Bill Berkrot (Reuters) - An experimental leukemia treatment that Roche Holding AG hopes will improve upon its best-selling cancer drug Rituxan delayed disease progression twice as long as chemotherapy, according to preliminary trial data releas...
Rituximab Works in ANCA-Linked Vasculitis (CME/CE)
Source: MedPage Today Rheumatology [2013.05.05]
WASHINGTON (MedPage Today) -- Rituximab given as adjunctive therapy to children with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis dramatically lowered the dosage of cyclophosphamide needed for treatment, researchers said here.
Cancer Cells' Achilles' Heel Revealed
Source: Arthritis / Rheumatology News From Medical News Today [2013.04.26]
Scientists from the Manchester Collaborative Centre for Inflammation Research (MCCIR) have discovered why a particular cancer drug is so effective at killing cells. Their findings could be used to aid the design of future cancer treatments. Professor Daniel Davis and his team used high quality video imaging to investigate why the drug rituximab is so effective at killing cancerous B cells...
Source: MedicineNet Biological Therapy Specialty [2011.09.08]
Title: Non-Hodgkin's Lymphoma
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 9/8/2011 12:00:00 AM